rs10490130

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004525.3(LRP2):​c.3667+355T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0985 in 152,256 control chromosomes in the GnomAD database, including 884 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.098 ( 884 hom., cov: 32)

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.109

Publications

7 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.159 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRP2NM_004525.3 linkc.3667+355T>G intron_variant Intron 24 of 78 ENST00000649046.1 NP_004516.2 P98164Q7Z5C0Q7Z5C1
LRP2XM_011511183.4 linkc.3667+355T>G intron_variant Intron 24 of 77 XP_011509485.1
LRP2XM_047444340.1 linkc.2743+355T>G intron_variant Intron 24 of 78 XP_047300296.1
LRP2XM_011511184.3 linkc.1378+355T>G intron_variant Intron 9 of 63 XP_011509486.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkc.3667+355T>G intron_variant Intron 24 of 78 NM_004525.3 ENSP00000496870.1 P98164
LRP2ENST00000443831.1 linkc.3256+355T>G intron_variant Intron 22 of 22 2 ENSP00000409813.1 E9PC35

Frequencies

GnomAD3 genomes
AF:
0.0984
AC:
14964
AN:
152138
Hom.:
882
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.162
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.0928
Gnomad ASJ
AF:
0.115
Gnomad EAS
AF:
0.00250
Gnomad SAS
AF:
0.0471
Gnomad FIN
AF:
0.0300
Gnomad MID
AF:
0.0791
Gnomad NFE
AF:
0.0820
Gnomad OTH
AF:
0.109
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0985
AC:
14994
AN:
152256
Hom.:
884
Cov.:
32
AF XY:
0.0948
AC XY:
7058
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.162
AC:
6743
AN:
41544
American (AMR)
AF:
0.0926
AC:
1416
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
399
AN:
3470
East Asian (EAS)
AF:
0.00250
AC:
13
AN:
5196
South Asian (SAS)
AF:
0.0469
AC:
226
AN:
4820
European-Finnish (FIN)
AF:
0.0300
AC:
319
AN:
10622
Middle Eastern (MID)
AF:
0.0884
AC:
26
AN:
294
European-Non Finnish (NFE)
AF:
0.0820
AC:
5578
AN:
67994
Other (OTH)
AF:
0.107
AC:
227
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
688
1376
2064
2752
3440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0860
Hom.:
1000
Bravo
AF:
0.107
Asia WGS
AF:
0.0540
AC:
189
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.8
DANN
Benign
0.61
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10490130; hg19: chr2-170099111; API